Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VIVK vs GSK✓SelectedUSD · GSKVIVK vs GSK performance historyLatest closeAs of+4.56%11/18
Stock and ETF performance explorer

VIVK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-99.9%
GSK return
-0.7%
Excess return
-99.3%
Maximum drawdown
-100.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+4.6%-1.3%+5.9%+4.3%
7D-0.4%-3.1%+2.8%-1.1%
30D-82.0%-0.9%-81.1%-81.6%
3M-98.6%-4.2%-94.4%-98.5%
6M-99.9%-1.6%-98.4%-99.9%
All-99.9%-0.7%-99.3%-99.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling